Reply to: "Liver-adipose tissue crosstalk in nonalcoholic fatty liver disease: the emerging role of remnant cholesterol": "BAT activation might improve NAFLD in patients, but this might require developing and/or maintaining functionally relevant levels of BAT mass.".


Por: Lee E, Korf H and Vidal-Puig A

Publicada: 1 mar 2024 Ahead of Print: 1 feb 2024
Resumen:


Filiaciones:
Lee E:
 Metabolic Research Laboratories, Wellcome Trust MRC Institute of Metabolic Science, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK

 Department of Medical Physiology, Graduate School of Medicine

 Research Institute of Disaster Medicine, Chiba University, Chiba, Japan

Korf H:
 Laboratory of Hepatology, CHROMETA Department, KU Leuven, Leuven, Belgium

:
 Metabolic Research Laboratories, Wellcome Trust MRC Institute of Metabolic Science, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK

 Centro de Investigación Príncipe Felipe, Valencia, Spain

 Cambridge University Nanjing Centre of Technology and Innovation, Nanjing, China
ISSN: 01688278





JOURNAL OF HEPATOLOGY
Editorial
ELSEVIER, RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, Países Bajos
Tipo de documento: Letter
Volumen: 80 Número: 3
Páginas: 112-114
WOS Id: 001188688100001
ID de PubMed: 37898347

MÉTRICAS